See also this year's filing and all EDGAR filings for this company.
PDF Report 0001419041_2023_Forte_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001419041, Forte Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 41,511,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 486,000 |
| 4 | LiabilitiesCurrent | 3,179,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,302,000 |
| 9 | ResearchAndDevelopmentExpense | 5,594,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 17,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 41,997,000 |
| 1 | Liabilities | 3,179,000 |
| 2 | Expenses | 13,896,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,818,000 |
| 5 | NetIncome | -13,879,000 |
| 6 | ComprehensiveNetIncome | -13,879,000 |
| 7 | BaseVar | 29,544,500 |
| 8 | EconomicCapitalRatio | 2.34 |